Last reviewed · How we verify
Glycopyrronium cloth, 2.4%
Glycopyrronium cloth, 2.4% is a Small molecule drug developed by Journey Medical Corporation. It is currently in Phase 2 development.
At a glance
| Generic name | Glycopyrronium cloth, 2.4% |
|---|---|
| Sponsor | Journey Medical Corporation |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis (PHASE2)
- A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis (PHASE2)
- An Open Label Study for Palmar Hyperhydrosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glycopyrronium cloth, 2.4% CI brief — competitive landscape report
- Glycopyrronium cloth, 2.4% updates RSS · CI watch RSS
- Journey Medical Corporation portfolio CI
Frequently asked questions about Glycopyrronium cloth, 2.4%
What is Glycopyrronium cloth, 2.4%?
Glycopyrronium cloth, 2.4% is a Small molecule drug developed by Journey Medical Corporation.
Who makes Glycopyrronium cloth, 2.4%?
Glycopyrronium cloth, 2.4% is developed by Journey Medical Corporation (see full Journey Medical Corporation pipeline at /company/journey-medical-corporation).
What development phase is Glycopyrronium cloth, 2.4% in?
Glycopyrronium cloth, 2.4% is in Phase 2.
Related
- Manufacturer: Journey Medical Corporation — full pipeline
- Compare: Glycopyrronium cloth, 2.4% vs similar drugs
- Pricing: Glycopyrronium cloth, 2.4% cost, discount & access